Study: Crestor benefits older patients with normal cholesterol levels

08/26/2010 | HealthDay News

AstraZeneca's statin Crestor appeared to reduce heart risk by 45% in older patients who have a normal cholesterol level but have a 5% to 10% risk of having cardiovascular disease within 10 years as well as an elevated level of the high-sensitivity C-reactive protein, U.S. researchers reported. Those with a 10-year risk of 11% to 20% saw their heart risk decline almost 50%.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN